Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Fluphenazine hydrochloride 1 mg oral tablet |
Is a |
False |
Fluphenazine hydrochloride |
Inferred relationship |
Some |
|
Fluphenazine hydrochloride 2.5 mg oral tablet |
Is a |
False |
Fluphenazine hydrochloride |
Inferred relationship |
Some |
|
Fluphenazine hydrochloride 5 mg oral tablet |
Is a |
False |
Fluphenazine hydrochloride |
Inferred relationship |
Some |
|
Fluphenazine hydrochloride 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluphenazine hydrochloride |
Inferred relationship |
Some |
|
Fluphenazine hydrochloride 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluphenazine hydrochloride |
Inferred relationship |
Some |
|
Fluphenazine hydrochloride 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluphenazine hydrochloride |
Inferred relationship |
Some |
|
fluphenazinhydrochlorid 5 mg/ml væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluphenazine hydrochloride |
Inferred relationship |
Some |
|
Fluphenazine hydrochloride 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluphenazine hydrochloride |
Inferred relationship |
Some |
|
fluphenazinhydrochlorid 1,5 mg + nortriptylin 30 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluphenazine hydrochloride |
Inferred relationship |
Some |
|
fluphenazinhydrochlorid 500 µg + nortriptylin 10 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluphenazine hydrochloride |
Inferred relationship |
Some |
|
fluphenazinhydrochlorid + nortriptylin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluphenazine hydrochloride |
Inferred relationship |
Some |
|
Fluphenazine hydrochloride 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluphenazine hydrochloride |
Inferred relationship |
Some |
1 |
Fluphenazine hydrochloride 1 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fluphenazine hydrochloride |
Inferred relationship |
Some |
1 |
Fluphenazine hydrochloride 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluphenazine hydrochloride |
Inferred relationship |
Some |
1 |
Fluphenazine hydrochloride 2.5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fluphenazine hydrochloride |
Inferred relationship |
Some |
1 |
Fluphenazine hydrochloride 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluphenazine hydrochloride |
Inferred relationship |
Some |
1 |
Fluphenazine hydrochloride 5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fluphenazine hydrochloride |
Inferred relationship |
Some |
1 |
fluphenazinhydrochlorid 1,5 mg + nortriptylin 30 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluphenazine hydrochloride |
Inferred relationship |
Some |
2 |
fluphenazinhydrochlorid 1,5 mg + nortriptylin 30 mg tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Fluphenazine hydrochloride |
Inferred relationship |
Some |
2 |
Fluphenazine hydrochloride 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluphenazine hydrochloride |
Inferred relationship |
Some |
1 |
Fluphenazine hydrochloride 10 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fluphenazine hydrochloride |
Inferred relationship |
Some |
1 |
fluphenazinhydrochlorid 500 µg + nortriptylin 10 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluphenazine hydrochloride |
Inferred relationship |
Some |
1 |
fluphenazinhydrochlorid 500 µg + nortriptylin 10 mg tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Fluphenazine hydrochloride |
Inferred relationship |
Some |
1 |
Fluphenazine hydrochloride 1 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fluphenazine hydrochloride |
Inferred relationship |
Some |
1 |
fluphenazinhydrochlorid 1,5 mg + nortriptylin 30 mg tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Fluphenazine hydrochloride |
Inferred relationship |
Some |
2 |
Fluphenazine hydrochloride 2.5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fluphenazine hydrochloride |
Inferred relationship |
Some |
1 |
Fluphenazine hydrochloride 5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fluphenazine hydrochloride |
Inferred relationship |
Some |
1 |
Fluphenazine hydrochloride 10 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fluphenazine hydrochloride |
Inferred relationship |
Some |
1 |
fluphenazinhydrochlorid 500 µg + nortriptylin 10 mg tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Fluphenazine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely fluphenazine hydrochloride 500 microgram and nortriptyline (as nortriptyline hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fluphenazine hydrochloride |
Inferred relationship |
Some |
2 |
Product containing precisely fluphenazine hydrochloride 500 microgram and nortriptyline (as nortriptyline hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fluphenazine hydrochloride |
Inferred relationship |
Some |
2 |
Product containing precisely fluphenazine hydrochloride 1.5 milligram and nortriptyline (as nortriptyline hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fluphenazine hydrochloride |
Inferred relationship |
Some |
2 |
Product containing precisely fluphenazine hydrochloride 1.5 milligram and nortriptyline (as nortriptyline hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fluphenazine hydrochloride |
Inferred relationship |
Some |
2 |